bit.bio has been named one of the UK's most successful tech companies in the prestigious Future Fifty report. Discover how our synthetic biology work is driving innovation.
09.10.2024
Sustainability Report
Presenting our first annual sustainability report, detailing our Corporate Sustainability Strategy and progress towards our aligne...
Exclusive interview with Genetic Engineering & Biotechnology News
CEO Mark Kotter, shares insights in an exclusive interview with Genetic Engineering & Biotechnology News about the revolutionary C...
bit.bio featured in Citeline by David Wild
bit.bio featured in Citeline where David Wild writes an article about the ever-evolving landscape of synthetic biology.
BiotechTV and Brad Loncar visit to bit.bio
bit.bio featured at BiotechTV, with Brad Loncar sharing news, stories, and educational videos about the biotechnology sector.
Sifted 100 Report highlights bit.bio as one of Europe's fastest-growing companies
bit.bio featured as one of Europe's fastest-growing startups in Sifted.
European Biotechnology feature: Biology as Software
bit.bio's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to indiv...
GEN synbio feature: bit.bio is retooling nature’s code
bit.bio's CEO, our cell programming approach and our products prominently covered in synthetic biology article.
Reprogramming Stars - featuring bit.bio CEO Mark Kotter
Editor-in-Chief Carlos-Filipe Pereira interviews our CEO for the Reprogramming Stars series in the journal Cellular Reprogramming.